Published in Obesity and Diabetes Week, March 28th, 2005
The drug, rimonabant, which the French company sanofi-aventis SA hopes to sell under the brand name Acomplia, trimmed nearly 16 pounds on average from people taking the optimal dose for 2 years, compared with 5.5 pounds for those who took dummy pills, doctors reported March 8, 2005, at a cardiology conference.
"The majority of the weight that was lost at 1 year is still maintained after 2 years. There is only a slight increase over that second year,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week